Tran B - Search Results

1

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.

Lin HM, Mak B, Yeung N, Huynh K, Meikle TG, Mellett NA, Kwan EM, Fettke H, Tran B, Davis ID, Mahon KL, Zhang A, Stockler MR, Briscoe K, Marx G, Crumbaker M, Stricker PD, Du P, Yu J, Jia S, Scheinberg T, Fitzpatrick M, Bonnitcha P, Sullivan DR, Joshua AM, Azad AA, Butler LM, Meikle PJ, Horvath LG. Lin HM, et al. Among authors: tran b. EBioMedicine. 2021 Oct;72:103625. doi: 10.1016/j.ebiom.2021.103625. Epub 2021 Oct 14. EBioMedicine. 2021. PMID: 34656931 Free PMC article.

2

Gene expression profiling of localized prostate cancer: getting answers to the questions that really matter.

Azad A, Tran B, Sengupta S, Lawrentschuk N. Azad A, et al. Among authors: tran b. J Clin Oncol. 2013 Sep 10;31(26):3295-6. doi: 10.1200/JCO.2013.51.0420. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940217 No abstract available.

3

Precision oncology using a clinician-directed, tailored approach to molecular profiling.

Lam M, Tran B, Beck S, Tie J, Herath D, Whittle J, Kwan EM, Fox SB, Fellowes A, Ananda S, Lipton L, Gibbs P, Rosenthal MA, Desai J. Lam M, et al. Among authors: tran b. Asia Pac J Clin Oncol. 2018 Feb;14(1):84-90. doi: 10.1111/ajco.12787. Epub 2017 Oct 30. Asia Pac J Clin Oncol. 2018. PMID: 29083093

4

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.

5

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.

Roohullah A, Cooper A, Lomax AJ, Aung J, Barge A, Chow L, McHale M, Desai J, Whittle JR, Tran B, de Souza P, Horvath LG. Roohullah A, et al. Among authors: tran b. Invest New Drugs. 2018 Oct;36(5):886-894. doi: 10.1007/s10637-018-0588-7. Epub 2018 May 16. Invest New Drugs. 2018. PMID: 29766337 Clinical Trial.

6

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.

Ha FJ, Spain L, Dowling A, Kwan EM, Pezaro C, Day D, Chia PL, Tran B, Pook D, Weickhardt AJ. Ha FJ, et al. Among authors: tran b. Asia Pac J Clin Oncol. 2019 Oct;15(5):e97-e102. doi: 10.1111/ajco.13109. Epub 2019 Jan 30. Asia Pac J Clin Oncol. 2019. PMID: 30701671

7

Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre study.

Kwan EM, Semira MC, Bergin ART, Muttiah C, Beck S, Anton A, Campbell D, Wong S, Rosenthal M, Gibbs P, Tran B. Kwan EM, et al. Among authors: tran b. Intern Med J. 2019 Nov;49(11):1378-1385. doi: 10.1111/imj.14262. Intern Med J. 2019. PMID: 30779277

8

Demonstrating the feasibility of collecting secondary, de-identified data on Australian patients receiving treatment as part of a Medicine Access Programme.

Lok SW, De Boer R, Cordwell C, Marx G, Fox P, Hasovits C, Rutovitz J, Harold M, Tran B, Wong HL, Gibbs P. Lok SW, et al. Among authors: tran b. Intern Med J. 2020 Jan;50(1):99-104. doi: 10.1111/imj.14265. Intern Med J. 2020. PMID: 30816606

9

Systematic Review of Efficacy and Health Economic Implications of Real-world Treatment Sequencing in Prostate Cancer: Where Do the Newer Agents Enzalutamide and Abiraterone Fit in?

Pereira-Salgado A, Kwan EM, Tran B, Gibbs P, De Bono J, IJzerman M. Pereira-Salgado A, et al. Among authors: tran b. Eur Urol Focus. 2021 Jul;7(4):752-763. doi: 10.1016/j.euf.2020.03.003. Epub 2020 Apr 6. Eur Urol Focus. 2021. PMID: 32273196 Review.

10

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index.

Day D, Guo C, Kanjanapan Y, Tran B, Spreafico A, Joshua AM, Wang L, Abdul Razak AR, Leighl NB, Hansen AR, Butler MO, Siu LL, Desai J, Bedard PL. Day D, et al. Among authors: tran b. JNCI Cancer Spectr. 2019 Sep 19;3(4):pkz071. doi: 10.1093/jncics/pkz071. eCollection 2019 Dec. JNCI Cancer Spectr. 2019. PMID: 32337489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,473 results

Search Page

Filters